2003 News Archive


12/19/2003 Adherex Announces Closing Of $21.5 Million Financing
12/16/2003 Adherex Announces New Private Placement Of $21 Million
12/10/2003 Adherex Announces Agreement To Acquire Non-Cancer Assets From Cadherin Biomedical
12/4/2003 Adherex Announces Private Placement Of $1.9 Million In Convertible Notes
11/28/2003 Adherex Reports First Quarter Results
10/2/2003 Adherex Issued New Us Patent For Vascular Targeting Agents
9/26/2003 Adherex Technologies Reports Year End Results
9/2/2003 Adherex Appoints Senior Harvard Physician To Chair Scientific And Clinical Advisory Committees
7/30/2003 Adherex Issued Additional Patent For The Prevention Of Cancer Metastasis
7/15/2003 Adherex Expands Patent Protection For Vascular Targeting Agents To Include Anti-Angiogenics
6/26/2003 Adherex Granted Patent For A New Method Of Killing Tumor Cells
6/24/2003 Adherex Closes Private Placement Investment Of $3.0 Million In Convertible Notes
6/11/2003 Adherex Issued New Patent Which Further Strengthens Anti-Cancer Portfolio
5/30/2003 Adherex Technologies Reports Third Quarter Results
5/13/2003 Adherex Signs Screening Agreement With National Cancer Institute
4/7/2003 Adherex Releases New Findings On Exherin™
2/28/2003 Adherex Technologies Reports Second Quarter Results
2/19/2003 New CEO Announced for Adherex

Home
About Us
Product Candidates
Preclinical Pipeline
Collaborations
Partnering
Press Releases
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
Events
Publications & Patents
Careers
Contact Us


© 2009 Adherex Technologies Inc. Site Map | Internet Disclaimer Statement | Printer Friendly Version site by webslingerz